LOUISVILLE, Ky.--(BUSINESS WIRE)--Feb. 23, 2009--
PharMerica Corporation (NYSE: PMC), a national provider of institutional
pharmacy and hospital pharmacy management services, today announced that
Denis R. Holmes has joined the Company as Senior Vice President,
Customer Services, effective immediately.
For the past 15 years, Mr. Holmes worked for Omnicare, a provider of
pharmaceutical care for the elderly, and served most recently as Vice
President, Operations. Prior to joining Omnicare, he was Executive Vice
President for Healthcare Prescription Services, Inc., a long-term care
pharmacy located in Indianapolis.
In commenting on Mr. Holmes joining the Company, Gregory S. Weishar,
PharMerica Corporation’s Chief Executive Officer, said, “Denis brings
considerable experience to our company. His twenty year career
encompasses all aspects of the institutional pharmacy business. He is a
great addition to our management team.”
PharMerica Corporation is a leading institutional pharmacy services
company servicing healthcare facilities in the United States. PharMerica
operates institutional pharmacies in 40 states. PharMerica’s customers
are institutional healthcare providers, such as nursing centers,
assisted living facilities, hospitals and other long-term care
providers. The Company also provides pharmacy management services to
long-term care hospitals.
From time to time, PharMerica Corporation makes “forward-looking
statements,” as defined within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Such forward-looking statements
are based on management's current expectations and involve known and
unknown risks, uncertainties, contingencies and other factors that could
cause results, performance or achievements to differ materially from
those anticipated. Forward-looking statements include, among
other things, statements relating to the Company’s current and expected
financial results, overall economic, financial and political conditions,
industry trends, as well as other especially relevant risks as detailed
in the Company’s filings with the Securities and Exchange Commission.
The information set forth herein should be read in light of such
risks. The Company assumes no obligation to update the
information contained in this press release.
Source: PharMerica Corporation
Michael J. Culotta, 502-627-7475
Vice President and Chief Financial Officer